Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Recommendations for the treatment of invasive fungal infection caused by filamentous fungi in the hematological patient

Autor: Barberan, Jose, Mensa, Josep, Vallejo Llamas, Juan Carlos, Jarque Ramos, Isidro, Garcia Ruiz, Juan Carlos, Cabrera Marin, Jose Rafael, Baltasar Tello, Patricia, Battle Massana, Montse, Besalduch Vidal, Juan, Calvo Vinas, Jose Manuel, Capote Huelva, Francisco Javier, Carreras Pons, Enric, Diaz Mediavilla, Joaquin, Diaz Morfa, Miguel L., Escalante Barrigon, Fernando, Fernandez Avellan, Pascual, Garzon Lopez, Sebastian, Grande Garcia, Carlos, Hernandez Maraver, Dolores, La Guia, Ana Lopez, Lopez Jimenez, Javier, Martin Chacon, Eusebio, Olave Rubio, Mayte, Perez Oteyza, Jaime, Ramirez Ramirez, Gemma, Rojas Contreras, Rafael, Roman Barbero, Alejandro, Rovira Tarrats, Montserrat, Rubio Felix, Daniel, Sanchez Godoy, Pedro, Sanchez Salinas, Andres, Sanz Alonso, Miguel A., La Serna Torroba, Javier, Valcarcel Ferreiras, David, Vazquez Lopez, Lourdes, Aguado Garcia, Jose M., Azanza Perea, Jose Ramon, Canton Moreno, Rafael, Cisterna Cancer, Ramon, Fortun Abete, Jesus, Garcia Rodriguez, Julio, Gomez Gomez, Joaquin, Gomez Garcia La Pedrosa, Elia, Montejo Baranda, Jose Miguel, Javier Pernan Garcia, F., Ruiz Camps, Isabel, Miguel Sanz, La Torre Cisneros, Julian

Publikováno v: ResearcherID
Publons
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Antifungal treatment in the hematological patient has reached a high complexity with the advent of new antifungals and diagnostic tests, which have resulted in different therapeutic strategies. The use of the most appropriate treatment in each case i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6ac3d6857209ea7c3b872fb6141e90fd
https://pubmed.ncbi.nlm.nih.gov/22173196

Phase II Trial to Evaluate the Efficacy and Safety of the Combination of Obinutuzumab and Bendamustine Treatment in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Autor: Garcia-Marco, Jose, Baltasar Tello, Patricia, Garcia, Esther González, Ríos Herranz, Eduardo, Ramirez Payer, Angel, Terol Castera, María José, Champ, Diana, Medina Perez, Angeles, Gironella, Mercedes, Rodríguez Fernández, Alicia, Muntañola Prat, Ana, Suárez Cabrera, Alexia, Jurado Chacón, Manuel, Fernández Zarzoso, Miguel, Rodríguez, Mercedes, Clavel, Juana, Dourdil Sahun, Maria Victoria, Ferra Coll, Christelle M, Pérez Persona, Ernesto, Marrero Santos, Carmen Milagros, Forés, Rafael, Delgado, Julio

Publikováno v: Blood; December 2017, Vol. 130 Issue: 1, Number 1 Supplement 1 p4321-4321, 1p